JMGPX
Price
$50.78
Change
+$0.05 (+0.10%)
Updated
Jun 2 closing price
Net Assets
12.8B
PMBCX
Price
$30.26
Change
-$0.18 (-0.59%)
Updated
Jun 2 closing price
Net Assets
24.56B
Interact to see
Advertisement

JMGPX vs PMBCX

Header iconJMGPX vs PMBCX Comparison
Open Charts JMGPX vs PMBCXBanner chart's image
JMGPX vs PMBCX Comparison Chart in %
View a ticker or compare two or three
VS
JMGPX vs. PMBCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMGPX is a StrongBuy and PMBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 24.6B vs. JMGPX (12.8B). JMGPX (0.00) and PMBCX (0.00) have matching dividends . JMGPX was incepted earlier than PMBCX: JMGPX (10 years) vs PMBCX (19 years). PMBCX (1.71) is less costly to investors than JMGPX (1.21). JMGPX is a more actively managed with annual turnover of: 67.00 vs. PMBCX (13.70). JMGPX has a lower initial minimum investment than PMBCX: JMGPX (0) vs PMBCX (1000). JMGPX annual gain was more profitable for investors over the last year : 3.19 vs. PMBCX (-15.11). JMGPX return over 5 years is better than : -1.15 vs. PMBCX (-9.16).
JMGPXPMBCXJMGPX / PMBCX
Total Expense Ratio1.151.7167%
Annual Report Gross Expense Ratio1.211.7171%
Fund Existence10 years19 years-
Gain YTD6.397-7.252-88%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets12.8B24.6B52%
Annual Yield % from dividends0.000.00-
Returns for 1 year3.19-15.11-21%
Returns for 3 years24.439.97245%
Returns for 5 years-1.15-9.1613%
Returns for 10 yearsN/A53.20-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GETGX48.02N/A
N/A
Victory Sycamore Established Value R
BRSDX16.51N/A
N/A
MFS Blended Research Small Cap Eq A
USISX20.28N/A
N/A
Victory Income Stock
CIPSX17.31N/A
N/A
Champlain Small Company Adv
SRFMX12.36N/A
N/A
Sarofim Equity